PSMA-specific CARTyrin T-stem cell memory therapy eliminates solid tumor in subcutaneous prostate cancer model

被引：0
|
作者：
Smith, Jenessa B. [1 ]
Codde, Rebecca [1 ]
Tan, Yening [1 ]
Barnett, Burton E. [1 ]
Hermanson, David [1 ]
Rengarajan, Srinivas [1 ]
Ostertag, Eric M. [1 ]
Shedlock, Devon J. [1 ]
机构：
[1] Poseida Therapeut, San Diego, CA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P490
引用
收藏
页数：2
相关论文
共 50 条
  • [21] MESENCHYMAL STEM CELL MEDIATED CANCER THERAPY INHIBITS TUMOR GROWTH IN THE TRANSGENIC ADENOCARCINOMA OF THE MOUSE PROSTATE (TRAMP) MODEL
    Buono, Roberta
    Abrate, Alberto
    Esposito, Antonio
    Canu, Tamara
    Del Maschio, Alessandro
    Benigni, Fabio
    Hedlund, Petter
    Montorsi, Francesco
    Cavarretta, Ilaria T. R.
    JOURNAL OF UROLOGY, 2013, 189 (04): : E203 - E203
  • [22] PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB "Super-Stimulation"
    Zuccolotto, Gaia
    Penna, Alessandro
    Fracasso, Giulio
    Carpanese, Debora
    Montagner, Isabella Monia
    Dalla Santa, Silvia
    Rosato, Antonio
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [23] Impact of Tumor Vascularity on Responsiveness to Antiangiogenesis in a Prostate Cancer Stem Cell-Derived Tumor Model
    Zhang, Kexiong
    Waxman, David J.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (05) : 787 - 798
  • [24] Stem cells from a malignant rat prostate cell line generate prostate cancers in vivo: a model for prostate cancer stem cell propagated tumor growth
    Hu, Wen-Yang
    Liu, Li-Feng
    Afradiasbagharani, Parivash
    Lu, Ran-Li
    Chen, Zhen-Long
    Hu, Dan-Ping
    Birch, Lynn A.
    Prins, Gail S.
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2022, 10 (06): : 377 - 389
  • [25] The use of artificial T cell receptors directed against human PSMA in an orthotopic mouse prostate cancer model
    Hassen, WA
    Gunset, G
    Brentjens, R
    Sadelain, M
    JOURNAL OF UROLOGY, 2003, 169 (04): : 210 - 210
  • [26] A novel chimeric antigen receptor CAR-T cell approach eliminates prostate cancer in a mouse tumour model
    Alzubi, J.
    Dettmer, V.
    Kuehle, J.
    Seidl, M.
    Taromi, S.
    Zeiser, R.
    Abken, H.
    Cathomen, T.
    Wolf, P.
    HUMAN GENE THERAPY, 2018, 29 (12) : A21 - A21
  • [27] INDUCTION OF PROSTATE-SPECIFIC T CELLS AND GRAFT-VERSUS-TUMOR EFFECT IN PATIENTS WITH ADVANCED PROSTATE CANCER AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Mattsson, J.
    Gertow, J.
    Henningsohn, L.
    Gustavsson, O.
    Uhlin, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S305 - S306
  • [28] Preclinical characterization of allogeneic CAR ?d T Cell therapy for prostate cancer targeting a novel dimeric epitope on PSMA
    Ramadoss, Nitya S.
    Speltz, Elizabeth
    Capillo, Tonya
    Meaddough, Erika
    Wang, Katherine
    Friedland, Natalia
    Wong, Jonathan
    Teague, Alexander G.
    Azameera, Aruna
    Gundurao, Smitha Rao Yelaguli
    Kaur, Ramandeep
    Smith-Boeck, Morgan
    Salum, Michael
    Chanthery, Yvan
    Green, Shon
    Herrman, Marissa
    Nishimoto, Kevin P.
    Aftab, Blake T.
    Bhat, Arun
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [29] 161Tb-PSMA-I&T and177Lu-PSMA-I&T treatment in T23 and ST4787 prostate cancer cell lines - a model representative of177Lu-PSMA-resistant prostate cancer phenotype
    Kirienko, M.
    Jachetti, E.
    Sulsenti, R.
    Pascali, C.
    Bogni, A.
    Colombo, M.
    Seregni, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S434 - S435
  • [30] Fas-mediated T cell deletion potentiates tumor antigen-specific tolerance in a mouse model of prostate cancer
    Stephanie S. Tseng-Rogenski
    Mohamed S. Arredouani
    Yilin C. Neeley
    Bin Lu
    Arul M. Chinnaiyan
    Martin G. Sanda
    Cancer Immunology, Immunotherapy, 2008, 57 : 1357 - 1365
12345